<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-antibiotics-09-00909">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Farrell</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Robbins</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Rhys-Williams</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Love</surname>
    <given-names>W.G.</given-names>
   </name>
  </person-group>
  <article-title>Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant 
   <italic>Staphylococcus aureus</italic> isolates during a 55-passage study
  </article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2011</year>
  <volume>55</volume>
  <fpage>1177</fpage>
  <lpage>1181</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.01285-10</pub-id>
  <?supplied-pmid 21149626?>
  <pub-id pub-id-type="pmid">21149626</pub-id>
 </element-citation>
</ref>
